Synaptogenix Inc (SNPX)

[runncoach]

Noble PR.
https://ih.advfn.com/p.php?pid=nmona&article=76552509&symbol=NTRP

Neurotrope to Present at NobleCon 14th Annual Institutional Investor Conference

Today : Thursday 25 January 2018

Click Here for more Neurotrope, Inc. Charts.
NEW YORK, Jan. 25, 2018 /PRNewswire/ -- Neurotrope, Inc. (NASDAQ: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzheimer's disease (AD), today announced that Dr. Daniel Alkon, President and CSO, will provide a corporate overview at the NobleCon 14th Annual Institutional Investor Conference to be held at the W Hotel in Fort Lauderdale, FL from January 29th – 30th, 2018.

Neurotrope's corporate presentation will take place on Tuesday, January 30th at 8:30 AM EST in Studio 2.

Dr. Alkon will also participate in a panel discussion entitled "Central Nervous System: Is there a cure for Alzheimer's on the Horizon?" on Monday, January 29th at 9:00 AM EST in Studio 1 of the W Hotel.

A video webcast of Neurotrope's presentation will be available here and on the Company's web site at www.neurotropebioscience.com. The video webcast will be archived on Neurotrope's website following the event.